New Duke study finds obesity rises with caloric intake, not couch time
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Oct-2025 18:11 ET (3-Oct-2025 22:11 GMT/UTC)
Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood. A new study by Mass General Brigham investigators identified an ancient immune pathway that is activated in patients with ACS and serves as a key driver of the disease. Blocking this pathway with clinically approved drugs alleviated disease severity in preclinical models. The results are published in Science Translational Medicine.